For referring DERMATOLOGISTS
Specialist psychiatric care alongside isotretinoin treatment.
Isotretinoin can be transformative for people living with acne. For those with a history of mental illness, however, treatment may raise additional questions about psychiatric stability, potential mood changes and appropriate monitoring.
While the relationship between isotretinoin and psychiatric symptoms remains uncertain, updated guidance from the Therapeutic Goods Administration (2025) and the Australasian College of Dermatologists (2024) highlights the importance of mental health assessment, ongoing monitoring and collaborative care where clinically indicated.
Specialist psychiatric input can help patients and dermatologists navigate these complexities through individualised assessment, thoughtful risk formulation and coordinated care, supporting informed treatment decisions while maintaining access to effective acne treatment.
Refer a Patient
Download Referral Information

90-minute
comprehensive
assessments
Australia-wide
telehealthFace to Face
Sunshine Coast
(QLD)
Comprehensive
GP correspondence
Collaborative
shared care
At a glance
Patients
Adults
Consultation format
Australia-wide via telehealth or in-person on the Sunshine Coast (Queensland)
Initial assessment
90-minute comprehensive psychiatric assessment
ADHD assessments
Two-stage assessment pathway
Reports
Comprehensive correspondence following assessment
Referrals accepted from
GPs, specialists and nurse practitioners
Referral required for Medicare
Yes
Medicare item number required
No
WhEN TO CONSIDER REFERRAL
Specialist assessment may be considered for patients with:
Pre-existing psychiatric illness
A history of self-harm, suicidality or psychiatric hospitalisation
Diagnostic uncertainty or complex psychotropic treatment
Concerns about psychiatric stability before commencing isotretinoin
Emerging or persistent psychiatric symptoms during treatment
What makes this practice different
Comprehensive 90-minute assessments
Time to understand the whole picture rather than simply reviewing symptoms.
Whole-person formulation
Assessment considers biological, psychological and social factors alongside each woman’s individual goals and circumstances.
Evidence-based psychiatry
Treatment recommendations are informed by contemporary psychiatric evidence and tailored to the individual.
Collaborative Shared Care
Treatment recommendations are informed by contemporary psychiatric evidence and tailored to the individual.
Evidence-based psychiatry
Treatment recommendations are informed by contemporary psychiatric evidence and tailored to the individual.
Who I see
The practice provides specialist psychiatric assessment and ongoing management for patients aged 18 to 65 years throughout Australia via telehealth and in-person on the Sunshine Coast (Queensland).
Patients commonly seek assessment and treatment for:
• Isotretinoin-related psychiatric assessment and mental health monitoring
• ADHD
• Anxiety disorders
• Depression and mood disorders
• Trauma-related disorders
• Personality disorders
• Burnout and chronic stress
• Perimenopausal mental health
• Relationship and emotional difficulties
• Life transitions
• Diagnostic clarification
• Medication optimisation
If you’re unsure whether a referral is appropriate, you’re welcome to contact the practice before referring.
When telehealth may not be the most appropriate model of care
The practice provides planned outpatient psychiatric care via telehealth throughout Australia, alongside face-to-face consultations on the Sunshine Coast, Queensland.
Telehealth offers accessible, individualised psychiatric care for many patients. However, some presentations may be better supported by in-person assessment, multidisciplinary involvement or more intensive follow-up. Face-to-face consultations may allow greater flexibility depending on individual clinical circumstances.
Telehealth may not be appropriare for :
• Children and adolescents under 18 years
Perinatal psychiatric care during pregnancy and the first 12 months postpartum, including women requiring in person assessment or monitoring because of an elevated risk of postpartum psychosis
Active eating disorders requiring specialist or multidisciplinary management
Acute suicidal ideation, acute suicidality or immediate risk of self-harm
Patients requiring urgent or crisis psychiatric assessment
Bipolar affective disorder where there is current instability, acute relapse, intensive medication adjustment or a need for frequent clinical monitoring
Severe alcohol or substance use disorders, particularly where specialist addiction treatment is required
Presentations requiring frequent or intensive psychiatric review beyond the scope of planned outpatient telehealth care
Presentations where regular face-to-face assessment, physical examination, multidisciplinary care or hospital-based services are likely to provide a more appropriate model of care
WorkCover and CTP matters
Medico-legal assessments, independent medical examinations and medico-legal reports
The practice welcomes referrals for patients with personality disorders where planned outpatient psychiatric care is clinically appropriate.
The referral journey
Referral received
Referral is sent securely via Medical Objects, Xestro or secure email.
Referral reviewed
Every referral is personally reviewed to ensure the practice is the right fit.
Appointment offered
If accepted, the patient will be contacted directly to arrange an appointment.
Comprehensive assessment
Thoughtful assessment and formulation tailored to the woman’s needs.
GP report
Comprehensive correspondence provided with patient consent.
Ongoing shared care
Collaborative care with you to support the best outcomes for your patient.
Who should send the referral, gp OR DERMATOLOGIST?
Referrals & Medicare Rebates
Referrals are welcomed directly from treating dermatologists or GPs.
The applicable Medicare item depends on the nature of the assessment and whether ongoing psychiatric care is indicated:
One-off assessment and management plan: MBS item 291 (telehealth equivalent 92435) requires a referral from a GP or participating nurse practitioner.
Initial psychiatric assessment with ongoing specialist care: MBS item 296 (telehealth equivalent 92437) may be eligible for a Medicare rebate following a direct dermatologist referral, subject to MBS requirements.
Patients presenting with a dermatologist referral should be aware that a Medicare rebate cannot be guaranteed, as the appropriate billing pathway may only become clear following assessment.
For greater certainty regarding rebate eligibility and Medicare Safety Net benefits, patients are encouraged to obtain a GP referral before their appointment.
dermatologist Referral information
To assist with assessment, please include the following where known or readily available:
Reason for referral
Relevant medical history
Current medications
Previous psychiatric history
Recent ECG, if available in case psychotropic medication is warranted
Recent and relevant pathology, investigations or specialist correspondence
Patient's General Practitioner Specialist details (for copies of Correspondance)
An ECG or additional investigations are not required prior to referral. Any further assessments can be arranged if clinically indicated.
Referring dermatologist do not need to specify a Medicare item number. The appropriate item is selected following assessment in accordance with the Medicare Benefits Schedule.
How to refer
Referrals can be sent securely via:
Medical Objects
(Your practice details)
Xestro Secure Messaging
(Your practice details)
Secure Email
referrals@drpriyomi.com.au
What happens next?
Every referral is personally reviewed. If accepted, the patient will be contacted directly to arrange an appointment. Following assessment, a comprehensive report outlining the diagnostic formulation, recommendations and management plan will be forwarded to the referring clinician with the patient’s consent.
Scope of Care & Urgent Mental Health Concerns
This service provides individualised psychiatric assessment and recommendations for patients with existing mental health conditions or emerging psychiatric concerns before or during isotretinoin treatment. Assessment considers psychiatric stability, potential risks and appropriate monitoring, supporting collaborative care with the treating dermatologist and their GP.
The practice provides planned, non-urgent outpatient psychiatric care and does not offer crisis or emergency services. Patients experiencing acute psychiatric deterioration, immediate safety concerns or requiring urgent assessment should seek care through their local GP, mental health crisis team or nearest emergency department.
For further information, please refer to our Emergency & Crisis Support page.
Refer a Patient